Thermo Fisher Scientific (TMO): CEO sold ~$1.8M
Marc N Casper, CEO at Thermo Fisher Scientific, sold ~$1.8M of Thermo Fisher Scientific shares.
- ~$1.8M
- Approx. value · 3,579 sh @ $501.65
- 116K
- Holds after · shares reported
- Traded
- Aug 22, 2025
- Filed
- Aug 26, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Dec 11, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Mar 3, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Jun 6, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Jun 10, 2025CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
- Jun 30, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
- Jul 2, 2025FDAFDA device approval: Oncomine Dx Express Test
- Jul 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Jul 22, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Jul 25, 2025InsiderOfficer sold ~$192K of TMO shares in the open market
- Jul 29, 2025Layoff notice · 5823 Newton Dr Carlsbad CA 92008Layoff notice filed in CA: 52 employees
- Jul 29, 2025Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 33 employees
- Aug 6, 2025Insider · 1 personInsiders: 15 sales (~$4.5M)
- Aug 7, 2025Insider · 1 personInsiders: 5 sales (~$3.6M)
- Aug 19, 2025InsiderCEO sold ~$101K of TMO shares in the open market
- Aug 19, 2025Congress · 1 personMembers of Congress: 4 sales
- Aug 20, 2025Insider · 1 personInsiders: 2 sales (~$148K)
- Aug 22, 2025 · this disclosureInsiderCEO sold ~$1.8M of TMO shares in the open market
What came next
- Aug 22, 2025Insider · 1 personInsiders: 2 sales (~$3.2M)
- Aug 28, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
- Aug 29, 2025Insider · 1 personInsiders: 2 sales (~$190K)
- Sep 5, 2025FDAFDA device clearance: The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
- Sep 5, 2025Insider · 1 personInsiders: 3 sales (~$200K)
- Sep 23, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Sep 25, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
- Oct 7, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 24, 2025Insider · 2 peopleInsiders: 6 sales (~$10.0M)
- Oct 27, 2025Insider · 1 personInsiders: 11 sales (~$4.1M)
- Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
- Oct 31, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Nov 7, 2025Insider · 1 personInsiders: 2 sales (~$5.8M)
- Nov 10, 2025Insider · 1 personInsiders: 2 sales (~$1.7M)
- Nov 12, 2025InsiderOfficer sold ~$622K of TMO shares in the open market
- Nov 13, 2025InsiderOfficer sold ~$2.76M of TMO shares in the open market
- Nov 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$6.4M)
- Dec 1, 2025InsiderOfficer sold ~$4.13M of TMO shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Thermo Fisher Scientific
For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.
Other recent filings by Marc N Casper, Chairman & CEO
- SEC Form 4 at Thermo Fisher Scientific (TMO)Aug 26, 2026
- SEC Form 4 at Thermo Fisher Scientific (TMO)Aug 26, 2026
- SEC Form 4 at Thermo Fisher Scientific (TMO)Aug 26, 2026
- SEC Form 4 at Thermo Fisher Scientific (TMO)Aug 26, 2026
- SEC Form 4 at Thermo Fisher Scientific (TMO)Aug 24, 2026
The full history of Marc N Casper, Chairman & CEO is on the profile page.
How this filing works
Explore the data
Common questions
Which Thermo Fisher Scientific (TMO) insider traded, and how much?
Marc N Casper, CEO at Thermo Fisher Scientific, sold ~$1.8M of Thermo Fisher Scientific shares. 3,579 shares at $501.65.
When did it happen, and when was it made public?
Traded: Aug 22, 2025. Filed: Aug 26, 2025. That is 4 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Thermo Fisher Scientific recently?
For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.
Does this mean TMO stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Thermo Fisher Scientific
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
Everything OQRO holds on this company is on its TMO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
